Allen & Overy has advised Exscientia on the deal.The collaboration will use AI to accelerate the discovery of small molecule therapeutic drug candidates in multiple therapeutic…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
